Horizon PSU Stim Interconnecting Cable - Product Usage: Horizon is indicated for the treatment of...
FDA Device Recall #Z-1965-2020 — Class II — March 23, 2020
Recall Summary
| Recall Number | Z-1965-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 23, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | The Magstim Company Limited |
| Location | Whitland, N/A |
| Product Type | Devices |
| Quantity | 71 units total |
Product Description
Horizon PSU Stim Interconnecting Cable - Product Usage: Horizon is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.
Reason for Recall
It was identified that there is a potential for the Stim Interconnecting high Voltage Cable located at the rear of the Rapid2 and Horizon power supply unit to fail.
Distribution Pattern
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, CA, CT, TN, IL, MN, MT, NC, NJ, NY, PA, SC, TX, WA, and the countries of Cyprus, China, Iran, Saudi Arabia, UK, Italy, Malaysia, Spain, Taiwan, Vietnam, Australia, Japan, Turkey, France and Israel.
Lot / Code Information
Product Number: 5188-00
Other Recalls from The Magstim Company Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0869-2021 | Class II | Neurosign 100, Product Number 9883-01. Intraope... | Dec 8, 2020 |
| Z-2884-2020 | Class II | Neurosign V4 Intraoperative Nerve monitor famil... | Jun 23, 2020 |
| Z-1966-2020 | Class II | Rapid2 PSU Stim Interconnecting Cable - Produ... | Mar 23, 2020 |
| Z-0836-2019 | Class II | HORIZON Ez Arm (Part of the HORIZON TMS Thera... | Oct 25, 2018 |
| Z-1352-2018 | Class II | Magstim Rapid Therapy System consisting of: Rap... | Sep 28, 2017 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.